IPO

Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing

SINGAPORE (Dec 11): Medtech company Biolidics is selling 27.5 million new shares at 28 cents each to retail and institutional investors in a private placement ahead of its listing on the Catalist Board of the Singapore Exchange.

Active management can deliver attractive returns amid tightening liquidity, says Charles Schwab

SINGAPORE (Dec 10): In the last few years, passive fund management has become increasingly popular among investors, as its returns have often outperformed those of active investing. One reason
for this outperformance can be attributed to the ultra-loose monetary policy environment in the aftermath of the global financial crisis in 2008.

In print this week

Dominant monopolists are a threat to us all

SINGAPORE (Dec 10): One afternoon back in the 1990s, when I worked for a Malaysian brokerage firm, I could not help overhearing one of my senior colleagues talking on the telephone to a fund manager about a company called Renong.

Designer bowls

SINGAPORE (Dec 10): The Washlet by TOTO is leading the way in toilet bowl design with its many new tech features

Management & Corporate Governance

Noble seeks court-ordered administration in Bermuda; says only way to avoid full liquidation

SINGAPORE (Dec 11): Noble Group plans to apply for a court-ordered administration in Bermuda on Dec 14 to complete the restructuring of the company into New Noble.

Malaysian authorities to take action against Top Glove over migrants' illegal overtime

(Dec 11): Malaysia said on Monday it would take action against Top Glove Corp. Bhd, the world’s top medical glovemaker, which admitted breaching labour laws after a Thomson Reuters Foundation expose found some migrants working illegal overtime.

Broker's Calls

City Developments kept at 'hold' despite trading at attractive valuations

SINGAPORE (Dec 11): DBS Group Research is reiterating its “hold” call on City Developments (CityDev) with a lower target price of $9.50.

This is despite the stock trading at attractive valuations at close to 2SD below historical P/NAV average.

Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing

9 hours 35 min ago

SINGAPORE (Dec 11): Medtech company Biolidics is selling 27.5 million new shares at 28 cents each...

Dominant monopolists are a threat to us all

10 hours 20 min ago

SINGAPORE (Dec 10): One afternoon back in the 1990s, when I worked for a Malaysian brokerage firm,...

Noble seeks court-ordered administration in Bermuda; says only way to avoid full liquidation

11 hours 2 min ago

SINGAPORE (Dec 11): Noble Group plans to apply for a court-ordered administration in Bermuda on Dec...

Active management can deliver attractive returns amid tightening liquidity, says Charles Schwab

Sponsored

SINGAPORE (Dec 10): In the last few years, passive fund management has become increasingly popular a

Pay out excess cash to maximise shareholder value

7 Dec 2018

SINGAPORE (Dec 10): Last Monday’s rally turned out to be short-lived, underscoring persistent volatility in equity markets, but the outlook for emerging markets may have just brightened some. Of significance, US Federal Reserve...

Will rising interest rates hurt corporates badly?

30 Nov 2018

SINGAPORE (Nov 30): November was another choppy month for Wall Street and global stock markets. Despite robust corporate earnings in the US, expectations are that earnings have peaked as interest rates start to rise and the US-China spat...

Nine Dragons ahead of the curve in supply strategy

23 Nov 2018

SINGAPORE (Nov 26): China-based stocks have been among the world’s worst performers this year, as fears of the US-China trade war and a cooling economy have hit stock prices hard. Our investment in Nine Dragons Paper Holdings (NDP), China’s...

Of Big Tech and S-curves

16 Nov 2018

SINGAPORE (Nov 19): US stocks rebounded higher at the start of the month, on the heels of the steep selloff in October, where the Dow Jones Industrial Average and Standard & Poor’s 500 index fell 5.1% and 6.9% respectively. The reprieve was...

IPO

Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing

SINGAPORE (Dec 11): Medtech company Biolidics is selling 27.5 million new shares at 28 cents each to retail and institutional investors in a private placement ahead of its listing on the Catalist Board of the Singapore Exchange.
Sponsored
Active management can deliver attractive returns amid tightening liquidity, says Charles Schwab
SINGAPORE (Dec 10): In the last few years, passive fund management has become increasingly popular among investors, as its returns have often outperformed those of active investing. One reason for this outperformance can be attributed to the ultra-lo...
In print this week

Dominant monopolists are a threat to us all

SINGAPORE (Dec 10): One afternoon back in the 1990s, when I worked for a Malaysian brokerage firm, I could not help overhearing one of my senior colleagues talking on the telephone to a fund manager about a company called Renong.
Sponsored
Designer bowls
SINGAPORE (Dec 10): The Washlet by TOTO is leading the way in toilet bowl design with its many new tech features It is the only room in the house where you can escape from family members for some alone time. Some even spend time in here reading a book or...
Management & Corporate Governance

Noble seeks court-ordered administration in Bermuda; says only way to avoid full liquidation

SINGAPORE (Dec 11): Noble Group plans to apply for a court-ordered administration in Bermuda on Dec 14 to complete the restructuring of the company into New Noble.
Malaysian authorities to take action against Top Glove over migrants' illegal overtime

(Dec 11): Malaysia said on Monday it would take action against Top Glove Corp. Bhd, the world’s top medical glovemaker, which admitted breaching labour laws after a Thomson Reuters Foundation expose found some migrants working illegal overtime.
Broker's Calls

City Developments kept at 'hold' despite trading at attractive valuations

SINGAPORE (Dec 11): DBS Group Research is reiterating its “hold” call on City Developments (CityDev) with a lower target price of $9.50.

This is despite the stock trading at attractive valuations at close to 2SD below historical P/NAV average.